BIRC5 and malignant colon neoplasm: γ-Tocotrienol and δ-tocotrienol, both of which are vitamin E derivatives, were found to reduce the level of expression and nuclear localisation of β-catenin in colon cancer cell lines, leading to reduced expression of cyclin D1, c-myc and survivin in these cells [71,72].